HomeProductsBioactive CompoundsAnti-Infective AgentsPrionRadotinib
Chemical structure of CAS 926037-48-1

Radotinib

CAS No.926037-48-1
MDL No.MFCD27956910
MFC27H21F3N8O
MW530.50
InChI KeyDUPWHXBITIZIKZ-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.926037-48-1
Product NameRadotinib

Biological Targets

ABL1·BCR

Associated Conditions

Parkinson disease·chronic myelogenous leukemia
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Radotinib is an effective inhibitor of native and kinase domain-mutant BCR-ABL1.

Leukemia • Vol. 29, Issue 9 • 2015
PMID: 25676420PMC: PMC4536190DOI: 10.1038/leu.2015.42

Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors.

Haematologica • Vol. 99, Issue 7 • 2014
PMID: 24705186PMC: PMC4077080DOI: 10.3324/haematol.2013.096776

Pushing the limits of targeted therapy in chronic myeloid leukaemia.

Nature reviews. Cancer • Vol. 12, Issue 8 • 2012
PMID: 22825216DOI: 10.1038/nrc3317

Documentation

Similar Products